Long-term patiromer adherence and renin-angiotensin aldosterone system inhibitor utilization: A retrospective study

This study provides evidence that patients adherent with patiromer use more RAASi than lower-adherence patients. Prior studies show RAASi use reduces mortality risk and kidney disease progression.